Multiple Sclerosis & Immune Disorders

Filter Your Results




Expert Perspective on Ocrelizumab and More

May 2017—Expert Perspective on Ocrelizumab

FDA Greenlights First New Treatment for ALS in More than Two Decades

Friday, May 05, 2017—The FDA has approved Radicava (edaravone, MT Pharma), as an intravenous infusion treatment for amyotrophic lateral sclerosis (ALS). Radicava is the first treatment approv…

MS Topography App Launches

Thursday, May 04, 2017—A new app that offers a new, visual way of understanding multiple sclerosis (MS) was recently launched at the American Academy of Neurology Annual Meeting in Boston. The app i…

AAN 2017 Meeting: New Data Reinforce Efficacy of Ocrelizumab

Wednesday, April 26, 2017—New data presented at the American Academy of Neurology (AAN) Annual Meeting in Boston show the benefits of ocrelizumab in relapsing multiple sclerosis (MS). In a pooled …

New Therapy for Chorea Associated with Huntington’s Disease Wins FDA Approval

Tuesday, April 04, 2017—The FDA approved Austedo (deutetrabenazine, Teva Pharmaceuticals) tablets for the treatment of chorea associated with Huntington’s disease (HD), making it just the secon…

In-Focus: Multiple Sclerosis

April 2017—Retooling Multiple Sclerosis Care

Filling the Gaps in the Multiple Sclerosis Treatment Landscape

With Patricia K. Coyle, MD

April 2017—The addition of a potential breakthrough agent may change the treatment arena, but wellness and early treatment remain the foundation of effective care.

Vitamin D: Considerations for Treatment, Prevention, and Risk in Multiple Sclerosis Care

Ellen Mowry, MD

April 2017—Preliminary signals are strong that vitamin D has a role to play in MS, but more research is needed to confirm the need for supplementation as a preventive or therapeutic measure.


Contact Info

For advertising rates and opportunities:
Wendy Terry

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.